Incentivized Smoking Cessation for Diabetics
1 other identifier
interventional
19
2 countries
2
Brief Summary
This pilot study aims to test the feasibility of providing incentives to patients with T2D contingent on remote biochemical verification using a smartphone carbon monoxide (CO) monitor. The investigators will use an ecological momentary assessment (EMA) smartphone application and CO sensor to monitor urges to smoke, stressors, smoking behaviors, and to validate continuous abstinence throughout the intervention. Two different contingency management structures will be explored to investigate the length of time incentives need to be offered.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2018
CompletedFirst Posted
Study publicly available on registry
May 17, 2018
CompletedStudy Start
First participant enrolled
June 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedDecember 6, 2019
December 1, 2019
1 year
May 4, 2018
December 4, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of CO readings completed
Feasibility of study determined by number of CO readings completed by each participant
12 weeks
Secondary Outcomes (2)
Quit outcomes
12 weeks
Cigarettes per day
12 weeks
Study Arms (3)
Short term incentives
EXPERIMENTALusual quit smoking treatment (counseling + medication) plus 6-weeks of payments for proof of smoking abstinence
Long term incentives
EXPERIMENTALusual quit smoking treatment (counseling + medication) plus 12-weeks of payments for proof of smoking abstinence
No incentives
NO INTERVENTIONusual quit smoking treatment (counseling + medication)
Interventions
Treatment arm participants will receive financial incentives ($20 per week) contingent on biochemically verified smoking abstinence submitted once daily for the time period allocated.
Eligibility Criteria
You may qualify if:
- Aged 18 to 75
- Type 2 diabetes diagnosis greater than 1 year prior to enrollment
- Currently smoking at least 5 cigarettes per day
- Self-reported quit attempt in past 12 months
You may not qualify if:
- Unwilling to make a quit attempt
- Unable to use smartphone iCO monitor following training session
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oklahomalead
- Cancer Research UKcollaborator
- University of Strathclydecollaborator
- University College, Londoncollaborator
Study Sites (2)
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
University of Strathclyde
Glasgow, Scotland, United Kingdom
Related Publications (1)
Martinez SA, Quaife SL, Hasan A, McMillan KA, Beebe LA, Muirhead F. Contingency management for smoking cessation among individuals with type 2 diabetes: protocol for a multi-center randomized controlled feasibility trial. Pilot Feasibility Stud. 2020 Jun 11;6:82. doi: 10.1186/s40814-020-00629-7. eCollection 2020.
PMID: 32537238DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sydney A Martinez, PhD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2018
First Posted
May 17, 2018
Study Start
June 22, 2018
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
December 6, 2019
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share